Skip to main content

Table 2 Patients characteristics of URSL according to stone position, ureteral or renal stones

From: Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study

Variables

Ureteral stone (N = 164)

Renal stone (N = 75)

p value

Age

   

 Median (range), years

65 (26–90)

69 (19–89)

0.011

Gender

   

 Male/female (%)

88/76 (53.7)

35/40 (46.7)

0.32

Body mass index

   

 Median (range), kg/m2

23.5 (14.3–37.2)

23.6 (15.9–41.8)

0.4

Comorbidities

   

 Diabetes yes/no (%)

30/134 (18.3)

24/51 (32.0)

0.019

 Hypertension yes/no (%)

61/103 (37.2)

42/33 (56.0)

0.006

 Hyperlipidemia yes/no (%)

22/142 (13.4)

14/61 (18.7)

0.29

Pre-URSL sepsis

   

 Yes/no (%)

51/113 (31.1)

33/42 (44.0)

0.05

Stone laterality

   

 Right/left/bilateral (%)

64/94/6 (39.0)/(57.3)/(3.7)

40/35 /0 (53.3)/(46.6)/(0)

0.044

Stone size (maximal diameter)

   

 Median (range), mm

7.2 (2.5–36.3)

11.2 (3.1–49.2)

 < 0.0001

Maximal hounsfield unit value

   

 Median (range), HU

618 (163–1593)

843 (293–1999)

 < 0.0001

Pre-URSL renal pelvic urine culture

   

 Positive/negative/not evaluated (%)

64/87/13 (39.0)/(53.0)/(8.0)

32/35/8 (42.7)/(46.7)/(10.7)

0.6

Pre-URSL blood culture

   

 Positive/negative/not evaluated (%)

14/56/94 (8.5)/(34.1)/(57.3)

13/20/42 (17.3)/(27.1)/(56.0)

0.11

Pre-URSL prophylactic antibiotics

   

 Yes/no (%)

30/134 (18.3)

17/58 (22.7)

0.43

Operation time

   

 Median (range), min

50.0 (14–220)

72.0 (25–147)

 < 0.0001

Pre-URSL ureteral stenting

   

 Yes/No (%)

149/15 (91.5)

73/2 (97.3)

0.07

Pre-URSL nephrostomy

   

 Yes/no (%)

15/149 (8.5)

2/73 (2.7)

0.07

Period from antipyresis to URSL

   

 Median (range), days

13.0 (1–79)

17.0 (3–90)

0.018

Pre-URSL ureteral stenting placement period

   

 Median (range), days

20 (0–124)

24 (2–117)

0.11

Using access sheath during URSL

   

 Yes/no (%)

74/90 (45.1)

75/0 (100)

 < 0.0001

Post-URSL futi

   

 Yes/no (%)

13/151 (7.9)

19/56 (25.3)

 < 0.0001

Initial stone free rate

   

 Yes/no (%)

158/6 (96.3)

59/16 (78.7)

 < 0.0001

  1. fUTI febrile urinary tract infection, CT computed tomography, URSL ureteroscopic lithotripsy